Carillion PLC
26 January 2004
26 January 2004
Carillion awarded first ProCure 21 contract at Rampton
Following its selection by the NHS as one of its principle supply chain partners
for the £7 billion ProCure 21 programme, Business and Construction Services
company Carillion has been awarded its first project under the ProCure 21
framework valued at £18 million.
The national High Secure Women's Unit project at Rampton Hospital in
Nottinghamshire will provide a dedicated facility for up to 60 women suffering
from a range of mental health problems. The Unit will also provide a number of
central facilities which will include, therapy, education, sport and leisure. It
will be built within the present secure perimeter of the Hospital.
Rampton Hospital forms part of Nottinghamshire Healthcare NHS Trust, and Mr.
John Ord, Head of Projects for the Trust, said: 'The ProCure 21 framework
underpins the Government's commitment to improving services using better capital
procurement through new partnerships with the private sector.'
Carillion Chief Executive, John McDonough, said: 'Health is a key growth market
for Carillion and we are delighted to have been selected as a ProCure 21 partner
and to have secured our first framework contract. Our Health Business delivers
fully integrated solutions to a number of NHS customers and will be drawing on
its extensive skills and experience, to provide a high quality, affordable
solution in this specialist field.'
Carillion is one of 12 principal supply chain partners for ProCure 21. Based on
partnering and lean construction principles, ProCure 21 comprises two elements:
£200m of Diagnostic & Treatment Centres (DTCs) and £7 billion of framework
contracts for any capital works over £1 million in value over a five-year
period.
Once all the necessary approvals have been obtained, work is due to start on the
Rampton site in summer 2004 with completion planned for early 2006.
Note to editors
Carillion recently added to its substantial portfolio of contracts in the Health
sector when it reached financial close on the new £700 million John Radcliffe
Hospital in Oxford. It is also currently the preferred bidder on three further
hospitals - the Queen Alexandra hospital project in Portsmouth and the William
Osler and Royal Ottawa Hospitals, in Ontario, Canada - with a combined value of
£1.6 billion.
Carillion has also been appointed preferred bidder for its first NHS Primary
Care contract worth around £80m for Birmingham & Solihull LIFT (Local
Improvement Finance Trust).
For further information contact
John Denning, Director Corporate Affairs, 01902 316384
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.